FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation.
Molecular Weight:
486.5
Purity:
>98% (HPLC)
CAS Number:
[1628416-28-3]
Formula:
C27H23FN4O4
Target:
CFTR
* VAT and and shipping costs not included. Errors and price changes excepted